ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
4.730
-0.010 (-0.21%)
At close: May 16, 2025, 4:00 PM
4.790
+0.060 (1.27%)
After-hours: May 16, 2025, 7:13 PM EDT
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $336.25 million as of May 16, 2025. Its market cap has decreased by -46.55% in one year.
Market Cap
336.25M
Enterprise Value
141.24M
1-Year Change
-46.55%
Ranking
Category
Stock Price
$4.73
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has decreased from $741.98M to $336.25M, a decrease of -54.68%. That is a compound annual growth rate of -14.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 336.25M | -40.96% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | 1.24B | 67.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.14B |
| Johnson & Johnson | 357.81B |
| AbbVie | 313.50B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 231.90B |
| Abbott Laboratories | 229.78B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |